X4 Pharmaceuticals

XFOR

Börsenwert 314 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Ikarian Capital Dallas, Texas	13,4 Mio. $	-983.733 $	-5.979	-7 %
2	2 Bain Capital Life Sciences Investors Boston, Massachusetts	11,2 Mio. $	–	–	–
3	ACM 3 AIGH Capital Management Baltimore, Maryland	8,8 Mio. $	+1,24 Mio. $	+7.522	+16 %
4	4 OrbiMed New York	7,27 Mio. $	–	–	–
5	5 Vanguard Group Malvern, Pennsylvania	4,94 Mio. $	+201.386 $	+1.224	+4 %
6	6 BVF Inc San Francisco, California	4,48 Mio. $	–	–	–
7	7 Sio Capital Management New York	4,26 Mio. $	–	–	–
8	ACM 8 Altium Capital Management New York	4,26 Mio. $	+4,41 Mio. $	+26.820	Neu
9	9 Axa Paris, France	3,12 Mio. $	+119.943 $	+729	+4 %
10	10 Monashee Investment Management Boston, Massachusetts	2,97 Mio. $	-72.887 $	-443	-2 %
11	11 Driehaus Capital Management Chicago, Illinois	2,68 Mio. $	-1,59 Mio. $	-9.652	-36 %
12	12 Worth Venture Partners Fort Lee, New Jersey	2,04 Mio. $	+284.146 $	+1.727	+15 %
13	13 New Leaf Venture Partners New York	1,77 Mio. $	–	–	–
14	14 Polaris Venture Management Co V Boston, Massachusetts	1,65 Mio. $	–	–	–
15	15 SV Health Investors Boston, Massachusetts	1,65 Mio. $	–	–	–
16	16 BlackRock New York	1,42 Mio. $	+28.299 $	+172	+2 %
17	17 Boothbay Fund Management New York	1,42 Mio. $	-332.518 $	-2.021	-18 %
18	18 Millennium Management New York	1,41 Mio. $	-650.721 $	-3.955	-31 %
19	19 Geode Capital Management Boston, Massachusetts	941.000 $	+88.518 $	+538	+10 %
20	20 Fidelity Investments Boston, Massachusetts	808.000 $	-327.911 $	-1.993	-28 %
21	21 Susquehanna International Group Bala Cynwyd, Pennsylvania	730.000 $	+543.611 $	+3.304	+255 %
22	22 Renaissance Technologies New York	637.000 $	-56.434 $	-343	-8 %
23	23 Cormorant Asset Management Boston, Massachusetts	550.000 $	–	–	–
24	24 Dimensional Fund Advisors Austin, Texas	389.000 $	-284.146 $	-1.727	-41 %
25	E 25 Ergoteles New York	365.000 $	-4.771 $	-29	-1 %

X4 Pharmaceuticals XFOR Börsenwert 314 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 314 Mio. $